[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"post-cabg\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:post-cabg":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":4},"100613970","smart-family-doctor-assisted-comprehensive-management-of-secondary-prevention-among-post-revascularization-patients-100613970",false,"NCT07273513","\"Smart Family Doctor\" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients","SMART II","Inclusion Criteria:\n\n* Age 18-80 years.\n* Underwent CABG or PCI more than 3 months prior and have concurrent hypertension, diabetes, and dyslipidemia.\n* At least one of the following criteria is meet:\n* Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg\n* HbA1c no less than 7%\n* LDL-C no less than 1.4 mmol\u002FL\n* Signed informed consent.\n\nExclusion Criteria:\n\n* History of heart failure or severe arrhythmias.\n* Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.\n* Pregnancy, lactation, or plans for pregnancy within the next year.\n* Cognitive, communication impairments, or limitations in daily activities.\n* Unable to use smartphone.","ALL","18 Years","80 Years",{"count":20,"type":21},951,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to evaluate the effect of an AI-assisted \"Smart family doctor\" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.",[27,28,29,30,31],"Hypertension","Diabete Mellitus","Hyperlipidemia","Post PCI","Post CABG",[33,34,35,36,37],"smartphone","AI-assisted","Revascularization management","metabolic management","Smart family doctor","NOT_YET_RECRUITING","2025-12-10",{"date":41,"type":42},"2025-12-18","ACTUAL",{"date":44,"type":21},"2026-01-15",{"date":46,"type":21},"2027-01-15",{"name":48,"class":49},"China National Center for Cardiovascular Diseases","OTHER_GOV"]